Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 24,851 results for: ina

Clear keywords
Showing: 4141 - 4160 of 24851 results

  2. Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody)

    Antibody
    #180093-rAb
    Purpose
    Anti-GluA1/GluR1 glutamate receptor (Rat) recombinant mouse monoclonal antibody
    Depositor
    James Trimmer
    Article
    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1
    Recommended Applications
    Immunohistochemistry and Western Blot
    Reactivity
    Mouse and Rat
    Source Species
    Mouse
    Isotype
    IgG2a
    Trial Size
    Available to purchase
    Available Since
    March 30, 2022
    Availability
    Industry, Academic Institutions, and Nonprofits
    Western Blot image by James Trimmer, UC Davis

  3. pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (AAV8)

    Viral Prep
    #84446-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (#84446). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] plasmid DNA. CAG-driven, Cre-dependent expression of Jaws-KGC-tdTomato-ER2 for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Article
    Chuong et al Nat Neurosci. 2014 Aug;17(8):1123-9. doi
    Promoter
    CAG
    Available Since
    June 21, 2024
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV-EF1a-C-CreintG (AAV1)

    Viral Prep
    #69571-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-C-CreintG (#69571). In addition to the viral particles, you will also receive purified pAAV-EF1a-C-CreintG plasmid DNA. EF1a-driven expression of optimized C-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-N-CretrcintG (Addgene catalog# 69570) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Connie Cepko
    Article
    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do
    Promoter
    EF1a
    Available Since
    Feb. 19, 2020
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV-EF1a-N-CretrcintG (AAV1)

    Viral Prep
    #69570-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-N-CretrcintG (#69570). In addition to the viral particles, you will also receive purified pAAV-EF1a-N-CretrcintG plasmid DNA. EF1a-driven expression of optimized N-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-C-CreintG (Addgene catalog# 69571) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Connie Cepko
    Article
    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do
    Promoter
    EF1a
    Available Since
    Feb. 19, 2020
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV-EF1a-mitoGFP-DIO (AAV2)

    Viral Prep
    #174112-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-EF1a-mitoGFP-DIO (#174112). In addition to the viral particles, you will also receive purified pAAV-EF1a-mitoGFP-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Maarten Kole
    Article
    Kole et al Nat Commun. 2022 Dec 9;13(1):7598. doi:
    Promoter
    EF1a
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV-EF1a-iCreV (AAV PHP.eB)

    Viral Prep
    #140135-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-EF1a-iCreV (#140135). In addition to the viral particles, you will also receive purified pAAV-EF1a-iCreV plasmid DNA. EF1a-driven, light-inducible iCreV recombinase for spatiotemporally precise optogenomic modifications. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hongkui Zeng
    Article
    Yao et al Nat Methods. 2020 Mar 23. pii: 10.1038/s
    Promoter
    EF1a
    Available Since
    Sept. 15, 2021
    Availability
    Academic Institutions and Nonprofits only

  10. AAV phSyn1(S)-DreO-bGHpA (AAV5)

    Viral Prep
    #50363-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from AAV phSyn1(S)-DreO-bGHpA (#50363). In addition to the viral particles, you will also receive purified AAV phSyn1(S)-DreO-bGHpA plasmid DNA. hSyn-driven Dre recombinase expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hongkui Zeng
    Article
    Madisen et al Neuron. 2015 Mar 4;85(5):942-58. doi: 10
    Promoter
    Syn
    Available Since
    May 29, 2019
    Availability
    Academic Institutions and Nonprofits only

  12. AAV phSyn1(S)-DreO-bGHpA (AAV Retrograde)

    Viral Prep
    #50363-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from AAV phSyn1(S)-DreO-bGHpA (#50363). In addition to the viral particles, you will also receive purified AAV phSyn1(S)-DreO-bGHpA plasmid DNA. hSyn-driven Dre recombinase expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hongkui Zeng
    Article
    Madisen et al Neuron. 2015 Mar 4;85(5):942-58. doi: 10
    Promoter
    Syn
    Available Since
    Aug. 18, 2020
    Availability
    Academic Institutions and Nonprofits only

  14. pTR-UF11 (AAV.A12.T)

    Viral Prep
    #157970-AAV.A12.T
    Purpose
    Ready-to-use AAV44.9(E531D) in PBS particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter
    Depositor
    Sergei Zolotukhin
    Article
    Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10
    Promoter
    chimeric CMV/Chicken Beta actin (CBA)
    Tags
    GFP
    Available Since
    Dec. 21, 2020
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV-EF1a-4mtGCaMP6f-DIO (AAV1)

    Viral Prep
    #179529-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-4mtGCaMP6f-DIO (#179529). In addition to the viral particles, you will also receive purified pAAV-EF1a-4mtGCaMP6f-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GCaMP8f. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Maarten Kole
    Article
    Kole et al Nat Commun. 2022 Dec 9;13(1):7598. doi:
    Promoter
    EF1a
    Available Since
    Feb. 6, 2026
    Availability
    Academic Institutions and Nonprofits only

  17. AAV-SYP1-miniSOG-T2A-mCherry (AAV8)

    Viral Prep
    #50972-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from AAV-SYP1-miniSOG-T2A-mCherry (#50972). In addition to the viral particles, you will also receive purified AAV-SYP1-miniSOG-T2A-mCherry plasmid DNA. Syn-driven, InSynC expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Roger Tsien
    Article
    Lin et al Neuron. 2013 Jul 24;79(2):241-53. doi: 1
    Promoter
    Syn
    Tags
    mCherry
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 4141 - 4160 of 24851 results